Showing 683 results
-
Media Release /- As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease(1)- In the Phase III trial, most patients…
-
Media Release /
-
Media Release /- As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease(1)- In the Phase III trial, most patients…
-
Media Release /
-
Media Release /RELAX-AHF study met one of its two primary endpoints in reducing dyspnea or shortness of breath, and was therefore positive under pre-specified criteriaNewly presented data show that at six months,…
-
Media Release /
-
Media Release /- Leeza and family share highs, lows and insights about caring for her mother with Alzheimer's disease in new video series- Ten national contest winners recognized for words of wisdom about finding…
-
Media Release /
-
Media Release /La iniciativa busca ayudar a cerrar la brecha del diagnóstico de los hispanos a través de recursos e información en español sobre la enfermedad de Alzheimer La compañía trabajará junto a Univision…
-
Media Release /The initiative aims to help close diagnosis gap for Hispanic Americans by providing in-language information and resources focused on Alzheimer’s diseaseThe company will work with Univision to help…
